The cancer therapeutics market size is expected to reach US$ 5,31,538.02 million by 2031 from US$ 2,30,423.56 million in 2024. The market is estimated to record a CAGR of 12.8% from 2025 to 2031.
Executive Summary and Global Market Analysis
The global cancer therapeutics market is experiencing remarkable growth, driven primarily by the escalating incidence of breast and lung cancers, alongside substantial investments in oncology research and development. Cancer therapeutics encompass a diverse range of treatments aimed at combating or curing cancerous conditions. Key therapeutic modalities commonly employed include chemotherapy, radiation therapy, immunotherapy, targeted therapy, hormone therapy, surgical interventions, and stem cell therapy. The fundamental goal of these strategies is to eliminate or control malignant cells, alleviate symptoms, and ultimately improve patient quality of life and survival outcomes. Treatment protocols frequently involve a combination of multiple therapies, meticulously tailored to the specific type and stage of cancer, as well as the patient’s overall health, to achieve optimal results.
Cancer Therapeutics Market Segmentation Analysis
The cancer therapeutics market is comprehensively analyzed across three key segments: therapy type, indication, and distribution channel.
In terms of therapy type, the market is segmented into chemotherapy, targeted therapy, radiation therapy, hormone therapy, and other therapeutic approaches. In 2024, chemotherapy held the dominant market share.
Regarding indications, the market encompasses blood cancer, lung cancer, breast cancer, colorectal cancer, prostate cancer, stomach cancer, cervical cancer, liver and intrahepatic bile duct cancer, thyroid cancer, and other specific indications. Lung cancer commanded the largest share of the market in 2024.
By distribution channel, the market is divided into hospital pharmacies, retail pharmacies, and online stores. Hospital pharmacies maintained the largest share of the market in 2024.
Cancer Therapeutics Market Drivers and Opportunities
According to the World Health Organization, various forms of cancer are responsible for approximately 1 in every 6 deaths globally. In 2022, an estimated 20 million new cancer diagnoses and 9.7 million cancer-related deaths were reported. This significant disease burden is projected to increase by approximately 77% by 2050, which will place considerable strain on global healthcare systems and communities. The American Cancer Society highlights that 5–10% of all cancers are inherited from parental lineage, with numerous cancer predisposition genes identified. For instance, mutations in hereditary cancer susceptibility genes such as BRCA1 and BRCA2 significantly elevate the risk of developing various cancers, including breast, ovarian, and prostate cancer. Breast cancer is globally recognized as the most prevalent cancer among women, with its incidence continuously rising due to contributing factors like environmental exposure, genetic susceptibility, hormonal imbalances, and evolving lifestyle choices. Furthermore, breast cancer remains one of the most frequently diagnosed cancers in the U.S.
Cancer Therapeutics Market Size and Share Analysis
Based on therapy type, the cancer therapeutics market is segmented into chemotherapy, targeted therapy, radiation therapy, hormone therapy, and other therapy types. The chemotherapy segment held the dominant market position in 2024. Chemotherapy agents, through their cytotoxic action, effectively halt or slow the proliferation of cancer cells. These drugs are systemically delivered via the bloodstream, targeting and disrupting cancer cell growth throughout the body. National Institutes of Health estimates indicate that approximately 650,000 cancer patients in the US undergo chemotherapy treatment annually in specialized oncology clinics.
Concerning indications, the market is segmented into blood cancer, lung cancer, breast cancer, colorectal cancer, prostate cancer, stomach cancer, cervical cancer, liver and intrahepatic bile duct cancer, thyroid cancer, and other indications. The lung cancer segment commanded the largest share of the market in 2024.
Download our Sample PDF Report
@ https://www.businessmarketinsights.com/sample/BMIRE00031299
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
